Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation

Clinical Nuclear Medicine

Volumn 25, Issue 1, 2000, Pages 7-10

  Kurtek, Richard W ^a   Lai, K Kay Yin ^a   Tauxe, W Newlon ^a,b   Eidelman, Benjamin H ^a   Fung, John J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Brain Death; Cerebellar Death; Cerebral Death; Organ Transplantation; Tc 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN DEATH; BRAIN HYPOXIA; BRAIN SCINTISCANNING; CADAVER DONOR; CEREBELLUM; CHILD; CLINICAL ARTICLE; COMA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; GLIOBLASTOMA; HEAD INJURY; HUMAN; INFANT; ORGAN TRANSPLANTATION; RELIABILITY; SAFETY;

ADOLESCENT; ADULT; BRAIN DEATH; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MIDDLE AGED; PATIENT CARE PLANNING; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DONORS;

EID: 0033985422     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200001000-00002     Document Type: Article

References (17)

1. Spieth ME, Azizullah AN, Kawada TK, Robyn KL, Siegel ME: Direct comparison of Tc-99m DTPA and Tc-99m HMPAO for evaluating brain death. Clin Nucl Med 19:867, 1994.
2. Thompson JR, Ashwal S, Schneider S, et al: Comparison of cerebral blood flow measurements by xenon computed tomography and dynamic brain scintigraphy in clinically brain dead children. Acta Radiol 369(Suppl):675, 1986.
3. Reid RH, Gulenchyn KY, Ballinger JR: Clinical use of technetium-99m HMPAO for determination of brain death. J Nucl Med 30:1621, 1989.
4. Abdel-Dayem HM, Behar RH, Sigurdsson GH, et al: The hollow skull: A sign of brain death in Tc-99m HMPAO brain scintigraphy. Clin Nucl Med 14:912, 1989.
5. Laurin NR, Driedger AA, Hurwitz GA, et al: Cerebral perfusion imaging with technetium-99m HMPAO in brain death and severe central nervous system injury. J Nucl Med 30:1627, 1989.
6. de la Riva A, Gonzalez FM, Llamas-Elvira JM, et al: Diagnosis of brain death: Superiority of perfusion studies with Tc-99m HMPAO over conventional radionuclide cerebral angiography. Br J Radiol 65:289, 1992.
7. Black PM: Brain death. N Engl J Med 299:338, 1978.
8. Salvoni U, Montesi A: Diagnostica-angiografica di morte cerebrale. Ann Ital Chir 47:88, 1971-72.
9. Van Bunnen Y, Delcour C, Wery D, et al: Intravenous digital subtraction angiography: Criteria of brain death. Ann Radiol 32:279, 1989.
10. Huet H, Leroy G, Toulas P, Coskun O, Theron J: Radiological confirmation of brain death: Digitised cerebral parenchymography. Neuroradiology 38:542, 1996.
11. Sharp PF, Smith FW, Gemmell HG, et al: Technetium-99m HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: Human volunteer studies. J Nucl Med 27:131, 1986.
12. Neirinckx RD, Canning LR, Piper IM, et al: Technetium-99m d,1 HMPAO: A new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191, 1987.
13. Guidelines for the Determination of Death. Report of the Medical Consultants on the Diagnosis of Death to the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA 246:2184, 1981.
14. Brandau W, Schober O, Knapp WH: Determination of brain death with technetium-99m HMPAO. J Nucl Med 31:2075, 1990.
15. Schauwecker DS: Tc-99m HMPAO brain survival study reveals flow to the cerebrum but none to the cerebellum. Clin Nucl Med 17:984, 1992.
16. Yatim A, Mercatello A, Coronel B, et al: Tc-99m HMPAO cerebral scintigraphy in the diagnosis of brain death. Transplant Proc 23:2491, 1991.
17. Mrhac L, Zakko S, Parikh Y: Brain death: The evaluation of semi-quantitative parameters and other signs in HMPAO scintigraphy. Nucl Med Commun 16:1016, 1995.